Key facts
- This page summarizes Richard Marshak's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 07 Oct 2026, 16:02.
Richard Marshak - 05 Oct 2026 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- TLSI
- Reported as of
- 05 Oct 2026
- Net transaction value
- -$1,427
- SEC form
- 4
- Accepted by SEC
- 07 Oct 2026, 16:02:44 UTC
- Prior SEC filing
- 01 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mary Szela, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Richard Marshak filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 07 Oct 2026.
Change
- Previous filing in this sequence was filed on 01 Jul 2026.
- Current net transaction value: -$1,427.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001982638
Primary reporting owner
Marshak Richard
- Relationship
- Chief Commercial Officer
- Address
- 6272 W. 91ST AVENUE, WESTMINSTER
- Signature
- /s/ Mary Szela, Attorney-in-Fact
- Signature date
- 07 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TLSI
transaction
Common Stock
Sale
- Transaction value
- -$1,427
- Shares
- -325
- Change %
- -0.25%
- Price
- $4.39
- Shares after
- 127,994
- Date
- 05 Oct 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person.